Jiang T - Search Results

1

Branched-Chain Amino Acid Metabolic Reprogramming Orchestrates Drug Resistance to EGFR Tyrosine Kinase Inhibitors.

Wang Y, Zhang J, Ren S, Sun D, Huang HY, Wang H, Jin Y, Li F, Zheng C, Yang L, Deng L, Jiang Z, Jiang T, Han X, Hou S, Guo C, Li F, Gao D, Qin J, Gao D, Chen L, Lin SH, Wong KK, Li C, Hu L, Zhou C, Ji H. Wang Y, et al. Among authors: jiang t, jiang z. Cell Rep. 2019 Jul 9;28(2):512-525.e6. doi: 10.1016/j.celrep.2019.06.026. Cell Rep. 2019. PMID: 31291585 Free article.

2

[Research progress of targeted therapy in non-small cell lung cancer brain metastases].

Jiang T, Zhou C. Jiang T, et al. Zhongguo Fei Ai Za Zhi. 2014 Nov;17(11):824-8. doi: 10.3779/j.issn.1009-3419.2014.11.09. Zhongguo Fei Ai Za Zhi. 2014. PMID: 25404274 Free PMC article. Review. Chinese.

3

FGFR1 amplification in lung squamous cell carcinoma: a systematic review with meta-analysis.

Jiang T, Gao G, Fan G, Li M, Zhou C. Jiang T, et al. Lung Cancer. 2015 Jan;87(1):1-7. doi: 10.1016/j.lungcan.2014.11.009. Epub 2014 Nov 20. Lung Cancer. 2015. PMID: 25433983 Review.

4

[Treatment of patients with ALK gene rearranged non-small cell lung cancer  after resistance to crizotinib].

Jiang T, Zhou C. Jiang T, et al. Zhongguo Fei Ai Za Zhi. 2015 Feb;18(2):69-74. doi: 10.3779/j.issn.1009-3419.2015.02.03. Zhongguo Fei Ai Za Zhi. 2015. PMID: 25676398 Free PMC article. Review. Chinese.

5

Clinical activity of the mutant-selective EGFR inhibitor AZD9291 in patients with EGFR inhibitor-resistant non-small cell lung cancer.

Jiang T, Zhou C. Jiang T, et al. Transl Lung Cancer Res. 2014 Dec;3(6):370-2. doi: 10.3978/j.issn.2218-6751.2014.08.02. Transl Lung Cancer Res. 2014. PMID: 25806323 Free PMC article.

6

[Research Progress of HGF/c-MET Inhibitor in the Treatment of Non-small Cell Lung Cancer].

Jiang T, Zhou C. Jiang T, et al. Zhongguo Fei Ai Za Zhi. 2015 Apr;18(4):240-4. doi: 10.3779/j.issn.1009-3419.2015.04.09. Zhongguo Fei Ai Za Zhi. 2015. PMID: 25936889 Free PMC article. Review. Chinese.

7

Feasibility of cytological specimens for ALK fusion detection in patients with advanced NSCLC using the method of RT-PCR.

Wang Y, Liu Y, Zhao C, Li X, Wu C, Hou L, Zhang S, Jiang T, Chen X, Su C, Gao G, Li W, Wu F, Li A, Ren S, Zhou C, Zhang J. Wang Y, et al. Among authors: jiang t. Lung Cancer. 2016 Apr;94:28-34. doi: 10.1016/j.lungcan.2016.01.014. Epub 2016 Jan 25. Lung Cancer. 2016. PMID: 26973203

8

Clinicopathological and prognostic significance of regulatory T cells in patients with non-small cell lung cancer: A systematic review with meta-analysis.

Zhao S, Jiang T, Zhang L, Yang H, Liu X, Jia Y, Zhou C. Zhao S, et al. Among authors: jiang t. Oncotarget. 2016 Jun 14;7(24):36065-36073. doi: 10.18632/oncotarget.9130. Oncotarget. 2016. PMID: 27153545 Free PMC article. Review.

9

EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain Metastases.

Jiang T, Su C, Li X, Zhao C, Zhou F, Ren S, Zhou C, Zhang J. Jiang T, et al. J Thorac Oncol. 2016 Oct;11(10):1718-28. doi: 10.1016/j.jtho.2016.05.013. Epub 2016 May 26. J Thorac Oncol. 2016. PMID: 27237825 Free article.

10

Long non-coding RNA BC087858 induces non-T790M mutation acquired resistance to EGFR-TKIs by activating PI3K/AKT and MEK/ERK pathways and EMT in non-small-cell lung cancer.

Pan H, Jiang T, Cheng N, Wang Q, Ren S, Li X, Zhao C, Zhang L, Cai W, Zhou C. Pan H, et al. Among authors: jiang t. Oncotarget. 2016 Aug 2;7(31):49948-49960. doi: 10.18632/oncotarget.10521. Oncotarget. 2016. PMID: 27409677 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,846 results

Search Page

Filters